We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Arterial Revascularization Superior in Bypass Surgery

By HospiMedica International staff writers
Posted on 25 Jul 2016
A new study concludes that diabetic patients who undergo coronary artery bypass surgery (CABG) have better long-term outcomes when arteries are used rather than veins.

Researchers at Royal Melbourne Hospital (RMH; Australia) and the University of Melbourne (Australia) reviewed 63,592 cases from the Australian and New Zealand Society of Cardiothoracic Surgeons (ANZSCTS) database, identifying 34,181 patients (34.1% diabetics), who underwent isolated CABG between 2001and 2012; total arterial revascularization (TAR) was performed in 35.9% of the patients. More...
The researchers then matched 6,232 diabetic and non-diabetic pairs.

The results showed that more diabetic patients survive when only arteries are used for bypasses during CABG surgery. Diabetic patients also experience fewer long-term complications from TAR/CABG than from conventional CABG. The researchers also found that TAR/CABG can be performed on diabetic patients without increasing the rate of complications, such as angina (chest pain), heart attacks, heart failure, and hospital readmissions. The study was published on July 14, 2016, in The Annals of Thoracic Surgery.

“Average conventional CABG surgery involves three to four grafts: one artery is usually used, along with vein grafts from the leg or thigh for the remaining new bypasses. In TAR/CABG surgery, only arteries are used,” said lead author James Tatoulis, MD, of RMH and the University of Melbourne. “For every 100 diabetic patients undergoing CABG surgery, four more will be alive at 10 years when arteries are used for the bypasses, rather than just one arterial graft together with veins.”

For patients with coronary artery disease (CAD), a coronary artery surgical bypass can be placed to reroute blood around blocked arteries to restore and improve blood flow and oxygen to the heart. To create the bypass graft, a surgeon harvests healthy blood vessels from another part of the body, often from the patient's leg or arm. This vessel becomes a graft, with one end attaching to a blood source above and the other end below the blocked area, creating a new conduit channel.

Related Links:
Royal Melbourne Hospital
University of Melbourne

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.